Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.
Orally administrable alginate-poly-L-lysine-alginate (APA) microcapsules containing live yeast cells was investigated for use in renal failure. At all times, yeast cells remain inside the microcapsules, which are then excreted in the stool. During their gastrointestinal passage, small molecules, like urea, diffuse into the yeast microcapsules where they are hydrolyzed. Orally administrating these microcapsules to uremic rats was found to decrease urea concentrations from 7.29 +/- 0.89 mmol/L to 6.12 +/- 0.90 mmol/L over a treatment period of eight weeks. After stopping the treatment, the urea concentrations increased back to uremic levels of 7.64 +/- 0.77 mmol/L. The analysis of creatinine concentrations averaged 39.19 +/- 4.33 micromol/L, 50.83 +/- 5.55 micromol/L, and 50.28 +/- 7.10 micromol/L for the normal-control, uremic-control and uremic-treatment groups, respectively. While creatinine concentrations for both uremic-control and uremic-treatment groups did not differ among each other (P > .05), they were, however, significantly higher than those of the normal control group (P < .05). Uric acid concentrations averaged 80.08 +/- 26.49 micromol/L, 99.92 +/- 26.55 micromol/L, and 86.49 +/- 28.42 micromol/L for the normal-control, uremic-control and uremic-treatment groups, respectively. There were no significant differences in both calcium and phosphate concentrations among all three groups (P > .05). The microbial populations of five tested types of bacteria were not substantially altered by the presence of the yeast APA encapsulated yeast (P > .05).
Coussa
Razek
R
Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Faculty of Medicine, McGill University, Montréal, QC, Canada H3A 2B4.
Martoni
Christopher
C
Bhathena
Jasmine
J
Urbanska
Aleksandra Malgorzata
AM
Prakash
Satya
S
D000284:Administration, Oral; D000464:Alginates / Q000008:administration & dosage*; D000818:Animals; D002118:Calcium / Q000097:blood; D002214:Capsules / Q000008:administration & dosage; D003404:Creatinine / Q000097:blood; D004195:Disease Models, Animal; D041981:Gastrointestinal Tract / Q000382:microbiology; D008297:Male; D010710:Phosphates / Q000097:blood; D011107:Polylysine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D051381:Rats; D017208:Rats, Wistar; D051437:Renal Insufficiency / Q000503:physiopathology / Q000628:therapy*; D012441:Saccharomyces cerevisiae / Q000502:physiology*; D014508:Urea / Q000097:blood*; D014511:Uremia / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D014527:Uric Acid / Q000097:blood
D000464:Alginates; D002214:Capsules; D010710:Phosphates; C051546:alginate-polylysine-alginate; D011107:Polylysine; D014527:Uric Acid; D014508:Urea; D003404:Creatinine; D002118:Calcium
J Biomed Biotechnol. 2004;2004(1):61-69
15123889
Science. 1964 Oct 23;146(3643):524-5
14190240
Biotechnol Bioeng. 1988 Jul 20;32(3):363-8
18584759
Artif Cells Blood Substit Immobil Biotechnol. 1996 May;24(3):201-18
8773740
Clin Nephrol. 1979 Feb;11(2):81-5
378490
Digestion. 2006;73 Suppl 1:5-12
16498248
N Engl J Med. 2004 Nov 25;351(22):2347-9; author reply 2347-9
15564557
Hypertens Res. 2001 Nov;24(6):691-7
11768729
Int J Artif Organs. 1990 Jul;13(7):404-6
2401576
Am J Kidney Dis. 2003 Jan;41(1):1-12
12500213
Methods Mol Biol. 1997;63:343-58
9113661
ASAIO Trans. 1991 Apr-Jun;37(2):80-7
1649615
Urol Res. 2005 Nov;33(5):372-5
16284877
Biotechnol Appl Biochem. 1990 Jun;12(3):227-36
1694439
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):742-6
8290593
Artif Organs. 1981;4 Suppl:137-42
7295080
Am J Physiol Renal Physiol. 2000 Jul;279(1):F3-F11
10894783
Trans Am Soc Artif Intern Organs. 1981;27:24-30
7036498
N Engl J Med. 1996 May 30;334(22):1448-60
8618585
Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):391-4
10532395
Am J Physiol Renal Physiol. 2000 Jan;278(1):F1-F12
10644651
Kidney Int Suppl. 1976 Dec;(7):S259-65
1070543
Trans Am Soc Artif Intern Organs. 1972;18(0):458-64, 484
4679903
Can J Physiol Pharmacol. 1966 Jan;44(1):115-28
5938982